Publications by authors named "Heather Iocca"

Background: Berotralstat (BCX7353) is an oral, once-daily inhibitor of plasma kallikrein recently approved for prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE). The objective of this report is to summarize results from an interim analysis of an ongoing long-term safety study of berotralstat in patients with HAE.

Methods: APeX-S is an ongoing, phase 2, open-label study conducted in 22 countries (ClinicalTrials.

View Article and Find Full Text PDF
Article Synopsis
  • Berotralstat (BCX7353) is a newly approved oral medication for preventing hereditary angioedema (HAE) attacks, showing positive results in reducing attack rates during a 24-week study.
  • The APeX-2 trial is a phase 3 study that assessed the long-term safety, tolerability, and effectiveness of berotralstat over 48 weeks in patients with HAE due to C1 esterase inhibitor deficiency.
  • Results indicated that berotralstat maintained a favorable safety profile with mostly mild side effects and significantly reduced monthly attack rates from the baseline to week 48.
View Article and Find Full Text PDF
Article Synopsis
  • There is a critical need for long-term treatment options for hereditary angioedema (HAE) in Japan, as current approved therapies are lacking; Berotralstat (BCX7353) is being developed as an oral, once-daily treatment to prevent angioedema attacks.
  • The APeX-J trial is a phase 3 study that involved patients with type 1 or 2 HAE and assessed the effectiveness of berotralstat in reducing the frequency of angioedema attacks compared to a placebo over a 24-week period.
  • Results showed that the higher dose of berotralstat (150 mg) significantly decreased the number of HAE attacks compared
View Article and Find Full Text PDF
Article Synopsis
  • Berotralstat (BCX7353) is an oral medication under investigation for preventing hereditary angioedema (HAE) attacks, aimed at assessing its efficacy and safety over a 24-week study (APeX-2 trial).
  • The trial involved 121 patients who were randomly assigned to receive either a daily dose of 110 mg or 150 mg of berotralstat, or a placebo, with the primary goal of measuring the frequency of HAE attacks.
  • Results indicated that both doses of berotralstat significantly reduced attack rates compared to placebo, with minimal side effects, and the higher 150 mg dosage showed the best safety profile.
View Article and Find Full Text PDF

Inflammation is increasingly recognized as an important contributor to a host of CNS disorders; however, its regulation in the brain is not well delineated. Nucleotide-binding domain, leucine-rich repeat, pyrin domain containing 3 (NLRP3) is a key component of the inflammasome complex, which also includes ASC (apoptotic speck-containing protein with a card) and procaspase-1. Inflammasome formation can be triggered by membrane P2X(7)R engagement leading to cleavage-induced maturation of caspase-1 and interleukin-1β (IL-1β)/IL-18.

View Article and Find Full Text PDF

The interplay between innate and adaptive immunity is important in multiple sclerosis (MS). The inflammasome complex, which activates caspase-1 to process pro-IL-1beta and pro-IL-18, is rapidly emerging as a pivotal regulator of innate immunity, with nucleotide-binding domain, leucine-rich repeat containing protein family, pyrin domain containing 3 (NLRP3) (cryopyrin or NALP3) as a prominent player. Although the role of NLRP3 in host response to pathogen associated molecular patterns and danger associated molecular patterns is well documented, its role in autoimmune diseases is less well studied.

View Article and Find Full Text PDF

The semaphorin and plexin family of ligand and receptor proteins provides important axon guidance cues required for development. Recent studies have expanded the role of semaphorins and plexins in the regulation of cardiac, circulatory and immune system function. Within the immune system, semaphorins and plexins regulate cell-cell interactions through a complex network of receptor and ligand pairs.

View Article and Find Full Text PDF

Inflammatory cytokines have been implicated in the pathology of multiple neurologic diseases, including multiple sclerosis. We examined the role of the TNF family member TWEAK in neuroinflammation. Cuprizone-fed mice undergo neuroinflammation and demyelination in the brain, but upon removal of cuprizone from the diet, inflammation is resolved and remyelination occurs.

View Article and Find Full Text PDF

Inflammation mediated by macrophages is increasingly found to play a central role in diseases and disorders that affect a myriad of organs, prominent among these are diseases of the CNS. The neurotoxicant-induced, cuprizone model of demyelination is ideally suited for the analysis of inflammatory events. Demyelination on exposure to cuprizone is accompanied by predictable microglial activation and astrogliosis, and, after cuprizone withdrawal, this activation reproducibly diminishes during remyelination.

View Article and Find Full Text PDF

Porphyromonas gingivalis (Pg) is a major etiologic agent for chronic periodontitis. Tissue destruction by Pg results partly from induction of host inflammatory responses through TLR2 signaling. This work examines the role of apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC), an adaptor molecule important for TLR-mediated caspase-1 activation.

View Article and Find Full Text PDF

Background: RNA interference (RNAi) technology is a powerful methodology recently developed for the specific knockdown of targeted genes. RNAi is most commonly achieved either transiently by transfection of small interfering (si) RNA oligonucleotides, or stably using short hairpin (sh) RNA expressed from a DNA vector or virus. Much controversy has surrounded the development of rules for the design of effective siRNA oligonucleotides; and whether these rules apply to shRNA is not well characterized.

View Article and Find Full Text PDF

The cytokine tumor necrosis factor (TNF)-alpha has previously been shown to prime hepatocytes to a state of replicative competence, but has not been shown to act as a complete mitogen for these cells. In the present study we have altered our previously described long-term dimethyl sulfoxide culture system to exclude all known hepatocyte mitogens from the culture media and enable us to directly examine the effects of TNF-alpha on primary rat hepatocytes. We have shown that cells maintained under these culture conditions retain the biochemical and morphological features of well-differentiated hepatocytes.

View Article and Find Full Text PDF